BI Asset Management Fondsmaeglerselskab’s Bio-Rad Laboratories Class A BIO Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-661	Closed	-$161K	–	765
2025 Q1	$161K	Sell	661 -980	-60%	-$295K	﹤0.01%	642
2024 Q4	$539K	Buy	+1,641	New	+$557K	0.01%	624
2024 Q2	–	Sell	-1,425	Closed	-$493K	–	649
2024 Q1	$493K	Buy	1,425 +646	+83%	+$212K	0.01%	532
2023 Q4	$252K	Buy	779 +323	+71%	+$101K	0.01%	635
2023 Q3	$163K	Hold	456	–	–	﹤0.01%	637
2023 Q2	$173K	Buy	456 +134	+42%	+$54.5K	﹤0.01%	627
2023 Q1	$154K	Buy	322 +33	+11%	+$15.4K	﹤0.01%	630
2022 Q4	$122K	Buy	289 +77	+36%	+$31.1K	﹤0.01%	591
2022 Q3	$88K	Sell	212 -135	-39%	-$67.3K	﹤0.01%	430
2022 Q2	$172K	Buy	+347	New	+$181K	0.01%	423

Other funds holding BIO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's BIO Position: Q2 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 661 shares — an estimated $161K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in BIO in Q2 2022 and held it in 10 quarters. The position peaked at $539K in Q4 2024. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

BI Asset Management Fondsmaeglerselskab reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
BI Asset Management Fondsmaeglerselskab sold 661 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $161K.
BI Asset Management Fondsmaeglerselskab first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and held it in 10 quarters.
BI Asset Management Fondsmaeglerselskab's Bio-Rad Laboratories Class A position peaked at $539K in Q4 2024.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2025, filed 14 Aug 2025.